Although the HGF/c‐Met pathway remains idle in livers under physiological conditions, it is activated in HCC tissues and contributes to tumor biological aggressiveness and poor prognosis (Bupathi et al., 2015; Giordano and Columbano, 2014). Here, MET is linked to hepatocellular carcinoma.